On the public citation graph

Chemical fragment arrays for rapid druggability assessment

0 signed · 41 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/anie.200352164openalex-snapshot
Immobilization of Natural Products on Glass Slides by Using a Photoaffinity Reaction and the Detection of Protein–Small‐Molecule Interactions
inferredcites →https://doi.org/10.1002/anie.201210006openalex-snapshot
Drug Discovery: A Modern Decathlon
inferredcites →https://doi.org/10.1002/cmdc.201500267openalex-snapshot
One Question, Multiple Answers: Biochemical and Biophysical Screening Methods Retrieve Deviating Fragment Hit Lists
inferredcites →https://doi.org/10.1007/978-1-4939-2269-7_3openalex-snapshot
Construction and Application of a Photo-Cross-Linked Chemical Array
inferredcites →https://doi.org/10.1007/s10822-009-9280-5openalex-snapshot
Lessons for fragment library design: analysis of output from multiple screening campaigns
inferredcites →https://doi.org/10.1016/0959-440x(95)80017-4openalex-snapshot
What makes a binding site a binding site?
inferredcites →https://doi.org/10.1016/j.cbpa.2011.02.020openalex-snapshot
Ligand specificity, privileged substructures and protein druggability from fragment-based screening
inferredcites →https://doi.org/10.1016/j.drudis.2011.02.002openalex-snapshot
Fragment screening to predict druggability (ligandability) and lead discovery success
inferredcites →https://doi.org/10.1016/j.drudis.2011.12.008openalex-snapshot
What makes a good drug target?
inferredcites →https://doi.org/10.1016/j.molimm.2007.10.030openalex-snapshot
The carbohydrate recognition domain of Langerin reveals high structural similarity with the one of DC-SIGN but an additional, calcium-independent sugar-binding site
inferredcites →https://doi.org/10.1021/bc500559eopenalex-snapshot
Third Generation Photo-Cross-Linked Small-Molecule Affinity Matrix: A Photoactivatable and Photocleavable System Enabling Quantitative Analysis of the Photo-Cross-Linked Small Molecules and Their Target Purification
inferredcites →https://doi.org/10.1021/cr050262popenalex-snapshot
Carbonic Anhydrase as a Model for Biophysical and Physical-Organic Studies of Proteins and Protein−Ligand Binding
inferredcites →https://doi.org/10.1021/jm049131ropenalex-snapshot
Druggability Indices for Protein Targets Derived from NMR-Based Screening Data
inferredcites →https://doi.org/10.1038/nbt1273openalex-snapshot
Structure-based maximal affinity model predicts small-molecule druggability
inferredcites →https://doi.org/10.1038/nrd892openalex-snapshot
The druggable genome
inferredcites →https://doi.org/10.1139/cjc-2015-0603openalex-snapshot
Fragment screening of N-acetylmannosamine kinase reveals noncarbohydrate inhibitors
inferredcites →https://doi.org/10.1177/1087057112465979openalex-snapshot
Parallel Screening of Low Molecular Weight Fragment Libraries: Do Differences in Methodology Affect Hit Identification?
inferredcites →https://doi.org/10.1177/1087057114565080openalex-snapshot
Large Scale Meta-Analysis of Fragment-Based Screening Campaigns: Privileged Fragments and Complementary Technologies
inferredcites →https://doi.org/10.3389/fimmu.2014.00323openalex-snapshot
Computational and Experimental Prediction of Human C-Type Lectin Receptor Druggability
inferredcites →https://doi.org/10.4155/fmc.14.3openalex-snapshot
Exploiting Structural Information for Drug-Target Assessment

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/9781118681121.ch2openalex-snapshot
A Structural View on Druggability
inferred← citeshttps://doi.org/10.1002/ange.201701943openalex-snapshot
Identifikation sekundärer Bindestellen auf DC‐SIGN mithilfe eines Fragment‐Screenings
inferred← citeshttps://doi.org/10.1002/ange.202109339openalex-snapshot
Allosterische, Wirkstoff‐zugängliche Bindestellen in β‐Propeller‐Lektinen
inferred← citeshttps://doi.org/10.1002/anie.201701943openalex-snapshot
Identification of Multiple Druggable Secondary Sites by Fragment Screening against DC‐SIGN
inferred← citeshttps://doi.org/10.1002/anie.202109339openalex-snapshot
Druggable Allosteric Sites in β‐Propeller Lectins
inferred← citeshttps://doi.org/10.1002/chem.202400660openalex-snapshot
Secondary Sites of the C‐type Lectin‐Like Fold
inferred← citeshttps://doi.org/10.1007/978-3-031-04998-9_12openalex-snapshot
Polypharmacology in Drug Design and Discovery—Basis for Rational Design of Multitarget Drugs
inferred← citeshttps://doi.org/10.1007/978-3-031-04998-9_18openalex-snapshot
General Strategies for Rational Design and Discovery of Multitarget Drugs
inferred← citeshttps://doi.org/10.1007/978-4-431-56529-1_1openalex-snapshot
Trends in Bioprobe Research
inferred← citeshttps://doi.org/10.1007/s10822-019-00197-wopenalex-snapshot
Elucidating the druggability of the human proteome with eFindSite
inferred← citeshttps://doi.org/10.1016/j.drudis.2016.11.021openalex-snapshot
Global vision of druggability issues: applications and perspectives
inferred← citeshttps://doi.org/10.1016/j.drudis.2018.02.015openalex-snapshot
Quantitative metrics for drug–target ligandability
inferred← citeshttps://doi.org/10.1016/j.jmgm.2016.12.019openalex-snapshot
First protein drug target’s appraisal of lead-likeness descriptors to unfold the intervening chemical space
inferred← citeshttps://doi.org/10.1016/j.mrl.2025.200179openalex-snapshot
The rise of NMR-integrated fragment-based drug discovery in China
inferred← citeshttps://doi.org/10.1021/acschembio.8b00875openalex-snapshot
CellFy: A Cell-Based Fragment Screen against C-Type Lectins
inferred← citeshttps://doi.org/10.1021/acsomega.9b00162openalex-snapshot
Computational and Experimental Druggability Assessment of Human DNA Glycosylases
inferred← citeshttps://doi.org/10.1021/jacs.1c07235openalex-snapshot
A Remote Secondary Binding Pocket Promotes Heteromultivalent Targeting of DC-SIGN
inferred← citeshttps://doi.org/10.1021/jacs.8b08644openalex-snapshot
Allosteric Inhibition of a Mammalian Lectin
inferred← citeshttps://doi.org/10.1038/s41467-026-68941-zopenalex-snapshot
Developments and challenges in hit progression within fragment-based drug discovery
inferred← citeshttps://doi.org/10.1039/d1md00238dopenalex-snapshot
Medicinal chemistry of the myeloid C-type lectin receptors Mincle, Langerin, and DC-SIGN
inferred← citeshttps://doi.org/10.3389/fmolb.2020.00180openalex-snapshot
Application of Fragment-Based Drug Discovery to Versatile Targets
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.